A, The An Overview of Serum Amyloid A in Obstetrical  Complications: Amyloid A in  Obstetrics

Alaa ali; wassan nori; Roaa Hamed

doi:10.70863/karbalajm.v14i1.849

Authors

Alaa Ibrahim Ali al mustansyriah university https://orcid.org/0000-0002-5461-306X
wassan nori Al-mustansyriah https://orcid.org/0000-0002-8749-2444
Roaa Mokram Hamed Al-mustansyriah university https://orcid.org/0000-0002-0881-6341

DOI:

https://doi.org/10.70863/karbalajm.v14i1.849

Keywords:

Amyloid A, inflammation, pregnancy.

Abstract

Serum Amyloid A (SAA) has remained a mystery since its discovery. Its remarkable evolutionary biodiversity and dynamic synthesis control have always held a powerful position in biology. It belongs to a family of apolipoproteins produced in response to cytokines released by activated monocytes and macrophages, isolated in the last 50 years. The lipophilicity of SAA spotlight its relation to lipid transport and metabolism. Evidence supported its role in the acute phase response, orchestrating inflammation, immunological reactions and trauma. SAA initiates many physiological reactions, such as fever, metabolic changes, and hormonal changes. SAA's participation in acute inflammatory response physiology has encouraged its use as a marker for the inflammatory process in obstetrical diseases. This review emphasizes human SAA protein as a sensitive biochemical marker for several common pregnancy complications.

References

Wilson PG, Thompson JC, Shridas P, McNamara PJ, de Beer MC, de Beer FC, Webb NR, Tannock LR. Serum amyloid A is an exchangeable apolipoprotein. Arteriosclerosis, thrombosis, and vascular biology. 2018 Aug;38(8):1890-900.

Sack GH. Serum amyloid and (SAA) proteins. Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins. 2010;421-436.‏

Jain CV, Jessmon P, Barrak CT, Bolnick A D, Kilburn BA, Hertz M, Armant DR. Trophoblast survival signalling during human placentation requires HSP70 activation of MMP2-mediated HBEGF shedding. Cell Death & Differentiation. 2017;24(10), 1772-1783.

Gerasimova EM, Fedotov SA, Kachkin DV, Vashukova ES, Glotov AS, Chernoff YO. Protein misfolding during pregnancy: new approaches to pre-eclampsia diagnostics. International journal of molecular sciences. 2019;20(24), 6183.‏

Gerasimova EM, Fedotov SA, Kachkin DV, Vashukova ES, Glotov AS, Chernoff YO, et al. Protein Misfolding during Pregnancy: New Approaches to Preeclampsia Diagnostics. International Journal of Molecular Sciences. 2019;20:6183.

Chuang E, Hori AM, Hesketh CD, Shorter J. Amyloid assembly and disassembly. J Cell Sci. 2018 Apr 13;131(8):jcs189928.

Mputhia Z, Hone E, Tripathi T, Sargeant T, Martins R, Bharadwaj P. Autophagy Modulation as a Treatment of Amyloid Diseases. Molecules. 2019 Sep 16;24(18):3372.

Matiiv AB, Trubitsina NP, Matveenko AG, Barbitoff YA, Zhouravleva GA, Bondarev SA. Amyloid and Amyloid-Like Aggregates: Diversity and the Term Crisis. Biochemistry (Mosc). 2020 Sep;85(9):1011-1034.

Scheres SHW. Amyloid structure determination in RELION-3.1. Acta Crystallogr D Struct Biol. 2020 Feb 1;76(Pt 2):94-101.

Spence T, Allsopp PJ, Yeates AJ, Mulhern MS, Strain JJ, McSorley EM. Maternal Serum Cytokine Concentrations in Healthy Pregnancy and Pre-eclampsia. J Pregnancy. 2021 Feb 23;2021:6649608.

Mangogna A, Agostinis C, Ricci G, Romano F, Bulla R. Overview of procalcitonin in pregnancy and in pre-eclampsia. Clin Exp Immunol. 2019 Oct;198(1):37-46.

Keaton SA, Heilman P, Bryleva EY, Madaj Z, Krzyzanowski S, Grit J, Miller ES, Jälmby M, Kalapotharakos G, Racicot K, Fazleabas A, Hansson SR, Brundin L. Altered Tryptophan Catabolism in Placentas From Women With Pre-eclampsia. Int J Tryptophan Res. 2019 Apr 8;12.

Swidan KH, Sweed MS, Abbas AM, Jewi MK. Serum Amyloid A in Preeclampsia, QJM: An International Journal of Medicine. 2020;113(1):hcaa056.022.

Uckan K, Sahin HG. Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia. J Obstet Gynaecol Res. 2018 Mar;44(3):440-

Sergeeva VA, Zakharova NV, Bugrova AE, Starodubtseva NL, Indeykina MI, Kononikhin AS. The high-resolution mass spectrometry study of the protein composition of amyloid-like urine aggregates associated with pre-eclampsia. 2020; European Journal of Mass Spectrometry, 26(2), 158-161.‏

Li C, Qin R, Liu R, Miao S, Yang P . Functional amyloid materials at surfaces/interfaces. Biomater Sci. 2018 Feb 27;6(3):462-472.

Nori, W., Shallal, F., Zghair, M.A.G. Aspirin Effect on Mid Luteal Phase Doppler Indices in Patients with Recurrent Pregnancy Loss. International Journal of Pharmaceutical Research, 2020, 12(3), pp. 2929–2934.

‏Lederer, W., Schaffenrath, H., Alomar-Dominguez, C., Thaler, J., Fantin, R., Dostal, L. Cerebrospinal beta-amyloid peptides (1-40) and (1-42) in severe pre-eclampsia and HELLP syndrome–a pilot study. Scientific reports. 2020;10(1), 1-7.‏

Nori W, Abdulghani M, Roomi AB, Akram W. To operate or to wait? Doppler indices as predictors for medical termination for first trimester missed abortion. Clinical and Experimental Obstetrics & Gynecology. 2021 Jan 27;48(1):168-74.

Jafari Z, Okuma M, Karem H, Mehla J, Kolb BE, Mohajerani MH. Prenatal noise stress aggravates cognitive decline and the onset and progression of beta amyloid pathology in a mouse model of Alzheimer's disease. Neurobiol Aging. 2019 May;77:66-86.

Kouza M, Banerji A, Kolinski A, Buhimschi IA, Kloczkowski A. Oligomerization of FVFLM peptides and their ability to inhibit beta amyloid peptides aggregation: consideration as a possible model. Phys Chem Chem Phys. 2017 Jan 25;19(4):2990-2999.

Ibrahim MI, Ramy AR., Abdelhamid AS, Ellaithy MI, Omar A, Harara RM. Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss. International Journal of Gynecology & Obstetrics. 2017; 136(3), 298-303.‏

Cao Y, Liu HC. Clinical Research on Detecting the Serum Amyloid A Level of Pregnant Woman in Early Primary Unexplained Recurrent Spontaneous Abortion. Journal of Modern Laboratory Medicine. 2017;32(6), 43-45.‏

Sandri S, Urban Borbely A, Fernandes I, de Oliveira EM, Knebel FH, Ruano R, Zugaib M, Filippin-Monteiro F, Bevilacqua E, Campa A. Serum amyloid A in the placenta and its role in trophoblast invasion. PLoS One. 2014 Mar 10;9(3):e90881.

Makieva S, Dubicke A, Rinaldi SF, Fransson E, Ekman-Ordeberg G, Norman JE. The preterm cervix reveals a transcriptomic signature in the presence of premature prelabor rupture of membranes. American journal of obstetrics and gynecology. 2017 Jun 1;216(6):602-e1.

Rani SU, Vidyayini R, Padmanaban S. Perinatal outcome in pregnancies with preterm premature rupture of membranes inclusive of extreme pre term. ObstetGynecol Int J. 2019;3(2):01-4.

Kari A, Sahhaf F, Abbasalizadeh F. Maternal, fetal and neonatal outcomes in mothers with diabetes mellitus or gestational diabetes that complicated with preterm premature rupture of the membrane (PPROM). Int J Womens Health Reprod Sci. 2017 Jan 1;5(1):66-71.

Narice BF, Trzeszcz M, Cohen M, Anumba DO. Acute Villitis and Intravascular Microorganisms in Fetal Vessels: A Case Report and Literature Review of an Unusual Histopathological Finding. Pediatric and Developmental Pathology. 2021 Feb 22:1093526621993333.

Boskabadi H, Zakerihamidi M. Evaluation of maternal risk factors, delivery, and neonatal outcomes of premature rupture of membrane: A systematic review study. Journal of Pediatrics Review. 2019 Apr 10;7(2):77-88.

Murthy S, Godinho MA, Guddattu V, Lewis LE, Nair NS. Risk factors of neonatal sepsis in India: A systematic review and meta-analysis. PloS one. 2019 Apr 25;14(4):e0215683.

Gursky O. Structural basis for vital function and malfunction of serum amyloid A: an acute-phase protein that wears hydrophobicity on its sleeve. Current Atherosclerosis Reports. 2020 Nov;22(11):1-1.

ElShourbagy MA, Hemeda HM, Islam BA, Abd Ellatif AS. Maternal serum amyloid a level in pregnancies complicated with preterm premature rupture of membranes. The Egyptian Journal of Hospital Medicine. 2017;68(1), 904-909.‏

Le Ray I, Mace G, Sediki M, Lirussi F, Riethmuller D, Lentz N, Ramanah R, Hoyek T, Spagnolo G, Laurent N, Goirand F. Changes in maternal blood inflammatory markers as a predictor of chorioamnionitis: a prospective multicenter study. American Journal of Reproductive Immunology. 2015 Jan;73(1):79-90.

Caloone J, Rabilloud M, Boutitie F, Traverse-Glehen A, Allias-Montmayeur F, Denis L, Boisson-Gaudin C, Hot IJ, Guerre P, Cortet M, Huissoud C. Accuracy of several maternal seric markers for predicting histological chorioamnionitis after preterm premature rupture of membranes: a prospective and multicentric study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016 Oct 1;205:133-40.